Cargando…

Interleukin 6 blockage-induced neutropenia in a patient with rheumatoid arthritis and resolved hepatitis B

The authors present a case report of a 59-year-old woman with rheumatoid arthritis after documented recovery from hepatitis C (HCV) infection and with resolved HBV infection who has been undergoing successful tocilizumab treatment. The patient experienced moderate to severe neutropenia after consecu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chmielińska, Magdalena, Olesińska, Marzena, Felis-Giemza, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847281/ https://www.ncbi.nlm.nih.gov/pubmed/27407267 http://dx.doi.org/10.5114/reum.2015.57640

Ejemplares similares

Treatment of rheumatic diseases and hepatitis B virus coinfection
por: Felis-Giemza, Anna, et al.
Publicado: (2014)

Discrepancies in assessment of patients with rheumatoid arthritis and secondary Sjögren's syndrome by DAS28-ESR and DAS28-CRP
por: Romanowska-Próchnicka, Katarzyna, et al.
Publicado: (2016)

Capillaroscopy – a role in modern rheumatology
por: Chojnowski, Marek M., et al.
Publicado: (2016)

Antimalarials – are they effective and safe in rheumatic diseases?
por: Haładyj, Ewa, et al.
Publicado: (2018)

Circulating miRNA-19b as a biomarker of disease progression and treatment response to baricitinib in rheumatoid arthritis patients through miRNA profiling of monocytes
por: Ciechomska, Marzena, et al.
Publicado: (2023)

Is intra-articular infliximab therapy a good alternative to radionuclide synovectomy for a patient with refractory pigmented villonodular synovitis?
por: Felis-Giemza, Anna, et al.
Publicado: (2021)

Immunity and early atherosclerosis in the course of systemic lupus erythematosus, mixed connective tissue disease and antiphospholipid syndrome
por: Haładyj, Ewa, et al.
Publicado: (2016)

Observational study of inflammatory arthritis treatment by etanercept originator switched to an etanercept biosimilar
por: Felis-Giemza, Anna, et al.
Publicado: (2019)

Microvascular damage – a marker of specific organ involvement in mixed connective tissue disease?
por: Ornowska, Sylwia, et al.
Publicado: (2021)

Relationship between type of skin lesions and nailfold capillaroscopy pattern in mixed connective tissue disease
por: Felis-Giemza, Anna, et al.
Publicado: (2021)

Association study between immune-related miRNAs and mixed connective tissue disease
por: Stypińska, Barbara, et al.
Publicado: (2021)

Injectable Gold-Induced Hepatitis and Neutropenia in Rheumatoid Arthritis
por: Uhm, Wan-Sik, et al.
Publicado: (2000)

Interferons (IFN-A/-B/-G) Genetic Variants in Patients with Mixed Connective Tissue Disease (MCTD)
por: Paradowska-Gorycka, Agnieszka, et al.
Publicado: (2019)

Subgroups of Sjögren’s syndrome patients categorised by serological profiles: clinical and immunological characteristics
por: Kontny, Ewa, et al.
Publicado: (2018)

Haptoglobin and Its Related Protein, Zonulin—What Is Their Role in Spondyloarthropathy?
por: Chmielińska, Magdalena, et al.
Publicado: (2021)

The Role of TNF-α and Anti-TNF-α Agents during Preconception, Pregnancy, and Breastfeeding
por: Romanowska-Próchnicka, Katarzyna, et al.
Publicado: (2021)

Increase of Circulating Monocyte–Platelet Conjugates in Rheumatoid Arthritis Responders to IL-6 Blockage
por: Mariscal, Anaís, et al.
Publicado: (2022)

Interleukin 6 and Rheumatoid Arthritis
por: Yoshida, Yuji, et al.
Publicado: (2014)

Interleukin-6 in Rheumatoid Arthritis
por: Pandolfi, Franco, et al.
Publicado: (2020)

Current Understanding of an Emerging Role of HLA-DRB1 Gene in Rheumatoid Arthritis–From Research to Clinical Practice
por: Wysocki, Tomasz, et al.
Publicado: (2020)

Lack of significant association between selected STAT3 polymorphisms and rheumatoid arthritis in the Polish population
por: Stypińska, Barbara, et al.
Publicado: (2018)

Interleukin-6 inhibitors in the treatment of rheumatoid arthritis
por: Hennigan, Stephanie, et al.
Publicado: (2008)

The Roles of Interleukin-6 in the Pathogenesis of Rheumatoid Arthritis
por: Hashizume, Misato, et al.
Publicado: (2011)

Mixed Connective Tissue Disease as Different Entity: Global Methylation Aspect
por: Filipowicz, Gabriela, et al.
Publicado: (2023)

FLT-1 gene polymorphisms and protein expression profile in rheumatoid arthritis
por: Paradowska-Gorycka, Agnieszka, et al.
Publicado: (2017)

Potential Mechanism of Fatigue Induction and Its Management by JAK Inhibitors in Inflammatory Rheumatic Diseases
por: Felis-Giemza, Anna, et al.
Publicado: (2023)

RORC2 Genetic Variants and Serum Levels in Patients with Rheumatoid Arthritis
por: Paradowska-Gorycka, Agnieszka, et al.
Publicado: (2016)

Interleukin-6 receptor in the recent-onset rheumatoid arthritis
por: Montes-Cano, Marco Antonio, et al.
Publicado: (2011)

Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor
por: Dayer, Jean-Michel, et al.
Publicado: (2010)

Neuroendocrine and neurophysiological effects of interleukin 6 in rheumatoid arthritis
por: Choy, Ernest H S, et al.
Publicado: (2018)

Role of Interleukin 6 Inhibitors in the Management of Rheumatoid Arthritis
por: Yip, Ronald Man Lung, et al.
Publicado: (2021)

IL-35, TNF-α, BAFF, and VEGF serum levels in patients with different rheumatic diseases
por: Wojdasiewicz, Piotr, et al.
Publicado: (2019)

KDR (VEGFR2) Genetic Variants and Serum Levels in Patients with Rheumatoid Arthritis
por: Paradowska-Gorycka, Agnieszka, et al.
Publicado: (2019)

Revising diagnosis of juvenile idiopathic arthritis in adults: a single-center retrospective study
por: Felis-Giemza, Anna, et al.
Publicado: (2023)

CDK7 inhibition suppresses rheumatoid arthritis inflammation via blockage of NF‐κB activation and IL‐1β/IL‐6 secretion
por: Hong, Honghai, et al.
Publicado: (2017)

Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis.
por: Robak, T, et al.
Publicado: (1998)

New era of treatment with biologics in rheumatology – is it time to shift paradigms in treatment with biologics?
por: Felis-Giemza, Anna
Publicado: (2019)

Interleukin-6 (IL-6) Receptor Antagonist Protects Against Rheumatoid Arthritis
por: Li, Songsong, et al.
Publicado: (2016)

Diagnostic Accuracy of Interleukin-6, Interleukin-8, and Interleukin-10 for Predicting Bacteremia in Children with Febrile Neutropenia
por: Şahbudak Bal, Zümrüt, et al.
Publicado: (2017)

Relationship between VEGF Gene Polymorphisms and Serum VEGF Protein Levels in Patients with Rheumatoid Arthritis
por: Paradowska-Gorycka, Agnieszka, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_h5emaud1i2ssn3mcs2hbtcmt47